These pathologies combine to create a toxic environment that drives neurodegeneration via neuronal and synaptic loss, leading to cognitive impairment.1 While Aβ and tau have been recognized as the primary signature of Alzheimer’s disease, the causal relationship between these two pathologies is not fully understood. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.